First Mercantile Trust’s Novavax NVAX Stock Holding History

First Mercantile Trust’s Portfolio NVAX Stock Details NVAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-632	Closed	-$115K	–	885
2021 Q1	$115K	Sell	632 -78	-11%	-$15.5K	0.01%	636
2020 Q4	$79K	Sell	710 -67	-9%	-$7.12K	0.01%	735
2020 Q3	$70K	Buy	+777	New	+$94.7K	0.01%	750
2015 Q2	–	Sell	-167	Closed	-$28K	–	1034
2015 Q1	$28K	Sell	167 -34	-17%	-$5.52K	﹤0.01%	994
2014 Q4	$24K	Buy	201 +36	+22%	+$3.76K	﹤0.01%	1010
2014 Q3	$14K	Buy	165 +8	+5%	+$723	﹤0.01%	1074
2014 Q2	$14K	Buy	157 +78	+99%	+$6.86K	﹤0.01%	1097
2014 Q1	$7K	Buy	79 +2	+3%	+$223	﹤0.01%	1240
2013 Q4	$8K	Sell	77 -33	-30%	-$2.33K	﹤0.01%	1129
2013 Q3	$7K	Buy	110 +4	+4%	+$225	﹤0.01%	1135
2013 Q2	$4K	Buy	+106	New	+$4.59K	﹤0.01%	1145

Other funds holding NVAX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

First Mercantile Trust's NVAX Position: Q2 2021 in Review

First Mercantile Trust sold out of Novavax (NVAX) in Q2 2021, closing a stake of 632 shares — an estimated $115K sold.

First Mercantile Trust first reported a position in NVAX in Q2 2013 and held it in 11 quarters. The position peaked at $115K in Q1 2021. 407 funds tracked by Wall St. Rank hold NVAX as of Q2 2021.

First Mercantile Trust reported no remaining Novavax position as of Q2 2021 after selling out during the quarter.
First Mercantile Trust sold 632 Novavax shares in Q2 2021, an estimated $115K.
First Mercantile Trust first reported a position in Novavax in Q2 2013 and held it in 11 quarters.
First Mercantile Trust's Novavax position peaked at $115K in Q1 2021.
407 funds tracked by Wall St. Rank held Novavax as of Q2 2021.

Based on First Mercantile Trust's 13F filing for Q2 2021, filed 10 Aug 2021.